Coeptis Therapeutics Inc Total Liabilities

Latest as of September 2025: $3.26 Million USD

Coeptis Therapeutics Inc total liabilities. Based on the latest financial reports, Coeptis Therapeutics Inc (COEP) has total liabilities worth $3.26 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Coeptis Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Coeptis Therapeutics Inc (2004–2024)

Total liabilities of Coeptis Therapeutics Inc from 2004 to 2024. This chart illustrates how Coeptis Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Coeptis Therapeutics Inc (COEP) long-term investment share to see how much of total assets are deployed in long-term investments.

Coeptis Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Coeptis Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Korea Computer & Systems Inc KQ:115500	Korea	₩10.67 Billion
GOLDGROUP MINING INC. F:55G0	Germany	€73.31 Million
PT Mulia Industrindo Tbk JK:MLIA	Indonesia	Rp2.10 Trillion
Trans Polonia S.A. WAR:TRN	Poland	zł366.63 Million
Optimax Holdings Sdn Bhd KLSE:0222	Malaysia	RM64.64 Million
Engenco Ltd AU:EGN	Australia	AU$94.56 Million
INSTAL KRAKÓW SA WAR:INK	Poland	zł123.34 Million
Magna Prima Bhd KLSE:7617	Malaysia	RM64.28 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Coeptis Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Coeptis Therapeutics Inc's balance sheet.

Liquidity & Leverage Metrics

Coeptis Therapeutics Inc Total Liabilities Ratios Explained

Coeptis Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Coeptis Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Coeptis Therapeutics Inc (2004–2024)

The table below shows the annual total liabilities of Coeptis Therapeutics Inc from 2004 to 2024.

Year	Total Liabilities	Change
2024-12-31	$5.04 Million	+45.61%
2023-12-31	$3.46 Million	+11.25%
2022-12-31	$3.11 Million	-29.50%
2021-12-31	$4.41 Million	-18.90%
2020-12-31	$5.44 Million	+3392.95%
2019-12-31	$155.85K	+151.08%
2018-12-31	$62.07K	-91.20%
2005-12-31	$705.22K	+126.80%
2004-12-31	$310.94K	--

About Coeptis Therapeutics Inc

NASDAQ:COEP USA Biotechnology

Market Cap

$79.05 Million

Market Cap Rank

#20493 Global

#4662 in USA

Share Price

$16.40

Change (1 day)

+1.17%

52-Week Range

$10.40 - $18.80

All Time High

$18.80